MT
Medici Therapeutics, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$14.8Msold at filing
Total offering$14.8M
Investors in the raise11count reported to the SEC
FiledDec 4, 2025first sale Nov 20, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Denitsa MilanovaExecutive Officer, Director
Matthew P. RabinowitzDirector
David ThompsonExecutive Officer
Nicholas P. RestifoExecutive Officer
Executive officers, directors and promoters as listed on the Form D.